Tempest Therapeutics Inc. Insider Trading
TPST
Insiders bought $1M on the open market and sold nothing.
Get an email when TPST's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Mar 24 | Matthew Angel CEO and President | Bought | 231,482 | $2.16 | 500K | New | Form 4 |
| Mar 24 | Matthew Angel CEO and President | Bought | 231,482 | $2.16 | 500K | 4.8% | Form 4 |
- Mar 24Matthew AngelCEO and President · bought 231,482 at $2.16500KNew position
- Mar 24Matthew AngelCEO and President · bought 231,482 at $2.16500K4.8% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with TPST
Spot a number that looks wrong? Check it in TPST's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing TPST
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.